
Horizon 2020: Using 2019 regulatory insights for 2020 success
Join us as we analyze the trends and developments affecting the industry now and in the future.
Session details:
December 11, 2019 | 11:00 AM EST
trends and outlook
Gain insight into global and regional regulatory trends of 2019. Understand which were the most impactful to the industry and reflect on the ramifications for your business.
Watch on-demand
and challenges
Get up to speed on the latest regulatory developments as we look forward to 2020. We'll discuss key trends and changes that pharma companies should anticipate for a successful year. Watch on-demand
Series presenters

Clarivate Analytics
Sarah earned her PhD in Immunology at the University of Texas followed by a postdoctoral fellowship at the University of Aberdeen. Prior to joining Clarivate Analytics, Sarah worked in Product and Portfolio Management in Life Sciences companies, building great products to enable drug development pipelines.

Clarivate Analytics
Blaine is a regulatory affairs professional with nearly 15 years of experience working in pharmaceutical product development, global lifecycle management and regulatory intelligence. She holds a M.S. in Pharmaceutical Science from the University of Florida and global RAC certification from RAPS.

Clarivate Analytics
Elizabeth has over 17 years experience in Regulatory Affairs. Prior to joining Clarivate she was a life science consultant with a specialty in regulatory affairs. Her consulting projects have been with top pharma and medical device companies. In addition, she’s worked with PE/VC companies to develop regulatory strategies for their portfolio companies.

Clarivate Analytics
John has 15 years of industry experience. His regulatory experience includes the analysis of content in the areas of pharmaceuticals, drug sales forecasting, clinical trials and medical device regulatory documentation. John earned his master’s degree in Science Communications from University of Bath and a BS in Pharmacology from the University of Edinburgh.

Clarivate Analytics
Christopher leads our Solutions Consulting practice at Clarivate Analytics. He brings 12 years of experience working across R&D and Medical Affairs including data/knowledge management, process engineering & project management roles at Intercept Pharmaceuticals, Accuray and Amylin Pharmaceuticals. Christopher received his M.S. in Information & Knowledge Strategy from Columbia University and his B.A. from the University of California – San Diego.